Nervonik
PrivateLast Round
Series B
Apr 27, 2026
Total Funding Raised
$65.5M
Company Overview
Nervonik is a therapeutic devices company that develops miniaturized, power-efficient neuromodulation implants and peripheral nerve stimulation (PNS) systems for chronic neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nervonik Comps
Public and private peers based on sector, stage, and business model.
Nervonik Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 27, 2026 | ||||
| Series A | Mar 4, 2025 |
Key People
Founding team and executive leadership
Nervonik Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amzak Health | Series B |
| U.S. Venture Partners | Series B, Series A |
| Foothill Ventures | Series A, Series B |
| ShangBay Capital | Series B |
| Lumira Ventures | Series B |
| Correlation Ventures | Series A |
| Elevage Medical Technologies | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
$53M round led by Amzak Health.
Nervonik Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nervonik's valuation, stock price, and market status.
